Neuroendocrine changes in heart failure and their clinical relevance (Q40430876)

20 September 2017

1 reference

title

Neuroendocrine changes in heart failure and their clinical relevance (English)

1 reference

20 September 2017

0 references

W. W. Parmley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586761

26 May 2024

language of work or name

1 reference

1 August 1995

1 reference

full work available at URL

20 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.4960180804

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586761

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fclc.4960180804

26 May 2024

1 reference

DOI

https://api.crossref.org/works/10.1002/CLC.4960180804

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.4960180804

26 May 2024

1 reference

DOI

https://api.crossref.org/works/10.1002/CLC.4960180804

26 May 2024

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

440-445

1 reference

Cardiac hypertrophy. Mechanical, neural, and endocrine dependence

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

Pathophysiology and current therapy of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Contractile performance of the hypertrophied and chronically failing cat ventricle

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Catecholamine cardiotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Neurohumoral mechanisms involved in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180804

7 January 2021

Verapamil preserves adenine nucleotide pool in cardiomyopathic Syrian hamster

1 reference

https://api.crossref.org/works/10.1002/CLC.4960180804

26 May 2024

Identifiers

DOI

1 reference

20 September 2017

1 reference